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What are the early signs of use? 
There are no early signs. There 
are only obvious signs common 
to all long-term users. What can 
be spotted is the transition from 
non-user to addict (one episode 
is sufficient for diagnosis). 
For example, an early draft of 
a manuscript may read “We 
replicated and extended a classic 
finding within an established 
theoretical framework…”; a 
later Sciagra™-influenced draft, 
however, would translate this to 
“We show for the first time… and 
provide a novel explanation for…”
Can Sciagra™ be taken as part 
of a career cocktail? Yes. In fact 
prolonged use of Sciagra™ can 
also lead to dependence on impact 
factors and of course the big “H” 
(paradoxically and dangerously 
a little “h”). In fact any h-index 
addicts should be referred to a 
Sciagra™ counsellor as this is 
probably the origin of the problem.
Can its use be prevented? 
It’s up to us really. Scientific 
parenting is important. Do 
supervisors know where their 
students are publishing at night? 
Do supervisors do an adverb 
and superlative check on every 
manuscript — “it’s completely vital 
that they perform this most critical 
of functions.” Do supervisors 
tell their students that it’s OK 
to publish in a journal that has 
“International” in its title? There is 
also talk of an anti-doping service 
which will rewrite Sciagra™ 
influenced papers in plain English. 
What can I say to users? Well, we 
all like a party and have dabbled in 
substances that may not enhance 
our dignity, so righteousness is 
probably not the correct response. 
The most therapeutically effective 
response to Sciagra™ users is: 
“yes, the journal is highly cited, 
but don’t worry, your paper won’t 
change that”. 
Where can I find out more? Call 
me, I know a cheap dealer outside 
the EU.
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googlemail.comand chisel when I suddenly 
realised there was a dark patch 
of organic matter on a freshly 
removed slab. After some 
cleaning I could identify this as 
a small part of a large claw.”
Late Palaeozoic arthropod 
groups evolved gigantic 
representatives generally 
attributed to a higher 
atmospheric oxygen 
concentration of 35 per cent 
compared with 21 per cent 
today.
Researchers have looked 
at a number of factors that 
may have allowed arthropods 
to reach such sizes, and 
constrained them under present 
conditions. The ability of the 
tracheae to transport oxygen 
to the tissues has been a 
subject of particular interest 
(see Curr. Biol. 17, R969–R971). 
But for this giant sea scorpion, 
the authors believe other 
mechanisms may have been 
involved, perhaps an ‘arms 





There is striking fossil evidence 
that much larger arthropods 
once existed on the planet, 
but a new find pushes the 
boundaries even further. From 
the sediments in a German 
quarry a giant claw has been 
recovered, whose owner was 
a sea scorpion. The size of 
the claw suggests that the 
organism possessing it had a 
body length of up to 2.5 metres.
Simon Braddy, at the 
University of Bristol, 
Markus Poschmann of the 
Archaeological Service in 
Mainz and O. Erik Tetlie at Yale 
University, report the find in 
Biology Letters of the Royal 
Society (published online), 
and suggest it came from the 
largest ever arthropod ever 
recorded.
The claw was found by 
Markus Poschmann in rocks 
390 million years old in a quarry 
near Pruen. “I was loosening 
pieces of rock with a hammer 
Marine giant: Markus Poschmann holds the fossil remains of the claw which has 
led to the projection of a body size for the invertebrate that possessed it of up to 
2.5 metres. (Picture: Simon Braddy.)
